UBS ASSET MANAGEMENT AMERICAS LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$12,162,882
+7.1%
242,192
-4.0%
0.01%0.0%
Q2 2023$11,353,1810.0%252,3490.0%0.01%0.0%
Q1 2023$11,353,181
-1.0%
252,349
-3.6%
0.01%
-16.7%
Q4 2022$11,464,419
-99.9%
261,685
-2.5%
0.01%
-40.0%
Q3 2022$17,689,817,000
+24.9%
268,475
-4.2%
0.01%
+42.9%
Q2 2022$14,161,084,000
-7.6%
280,362
+16.8%
0.01%0.0%
Q1 2022$15,329,667,000
-39.0%
239,976
+2.3%
0.01%
-30.0%
Q4 2021$25,128,757,000
-6.4%
234,607
-10.1%
0.01%
-9.1%
Q3 2021$26,841,739,000
+8.1%
261,081
-7.5%
0.01%0.0%
Q2 2021$24,837,177,000
-1.1%
282,369
+9.4%
0.01%0.0%
Q1 2021$25,101,384,000
-33.8%
258,165
-23.6%
0.01%
-38.9%
Q4 2020$37,906,925,000
+35.9%
338,002
+12.3%
0.02%
+20.0%
Q3 2020$27,899,178,000
+28.1%
300,962
+7.8%
0.02%
+15.4%
Q2 2020$21,778,536,000
+304.0%
279,212
+202.9%
0.01%
+225.0%
Q1 2020$5,390,277,000
-51.2%
92,173
-33.1%
0.00%
-42.9%
Q4 2019$11,043,323,000
+10.6%
137,852
+1.4%
0.01%0.0%
Q3 2019$9,987,659,000
-19.9%
135,942
+2.9%
0.01%
-22.2%
Q2 2019$12,461,747,000
+19.6%
132,108
+1.5%
0.01%
+12.5%
Q1 2019$10,418,907,000
+53.7%
130,155
+3.5%
0.01%
+33.3%
Q4 2018$6,778,429,000
-35.0%
125,736
-5.9%
0.01%
-25.0%
Q3 2018$10,430,299,000
+29.5%
133,619
+5.3%
0.01%
+33.3%
Q2 2018$8,054,343,000
-18.7%
126,880
+17.5%
0.01%
-25.0%
Q1 2018$9,903,967,000
+19.6%
108,004
-1.6%
0.01%
+14.3%
Q4 2017$8,279,113,000
+9.4%
109,788
+1.0%
0.01%0.0%
Q3 2017$7,570,551,000
+1044.8%
108,663
+732.6%
0.01%
+600.0%
Q2 2017$661,294,000
+229.7%
13,051
+160.2%
0.00%
Q1 2017$200,550,000
+61230.3%
5,015
-54.5%
0.00%
Q3 2016$327,000
+59.5%
11,015
+9.1%
0.00%
Q2 2016$205,000
+12.6%
10,1000.0%0.00%
Q1 2016$182,000
-94.4%
10,100
-91.9%
0.00%
-100.0%
Q4 2015$3,278,000
+13.9%
124,431
-7.8%
0.00%
+33.3%
Q3 2015$2,879,000
-8.9%
134,921
+13.1%
0.00%0.0%
Q2 2015$3,160,000119,2790.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders